Celltrion, Inc. Share Price
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,72,700.00 KRW | +7.60% |
|
-1.09% | +0.19% |
| 19/06 | South Korean Shares Snap Six-Day Winning Streak on Profit-Booking | MT |
| 19/06 | Celltrion's EU Clinical Trial Nod for Crohn's Disease Drug Lapses | MT |
| Market Cap | 37,95300Cr 2.46TCr 2.17TCr 2TCr 1.87TCr 3.5TCr 2,32000Cr 3.57TCr 24TCr 9.3TCr 1,14500Cr 9.24TCr 9.04TCr 3,98200Cr | P/E 2026 * |
29.1x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4TCr 2.6Cr 2.29Cr 2.11Cr 1.97Cr 3.7Cr 244.82Cr 3.77Cr 25Cr 9.82Cr 120.77Cr 9.75Cr 9.54Cr 420.17Cr | EV / Sales 2026 * |
7.52x | EV / Sales 2027 * | 6.36x |
| Free-Float |
53.67% | Yield 2026 * |
0.43% | Yield 2027 * | 0.46% |
| 1 day | +7.60% | ||
| 1 week | -1.09% | ||
| Current month | -6.00% | ||
| 1 month | -8.74% | ||
| 3 months | -9.15% | ||
| 6 months | -0.37% | ||
| Current year | +0.19% |
| 1 week | 1,59,200 |  | 1,75,500 |
| 1 month | 1,58,500 | | 1,92,380.95 |
| Current year | 1,58,500 | | 2,39,047.62 |
| 1 year | 1,51,238.1 | | 2,39,047.62 |
| 3 years | 1,14,250.83 | | 2,39,047.62 |
| 5 years | 1,14,250.83 | | 2,47,058.06 |
| 10 years | 61,908.65 | | 3,25,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/01 | Sell | 1,000 | 0.0004% | |||
| 16/01 | Sell | 1,000 | 0.0004% | |||
| 16/01 | Sell | 500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.60% | -1.09% | +12.49% | +20.82% | 2.46TCr | |
| +0.49% | +7.97% | -6.19% | +1.72% | 4.54TCr | |
| +0.15% | +7.61% | +324.11% | +565.24% | 3.61TCr | |
| +0.36% | +5.50% | +3.87% | +54.57% | 3.08TCr | |
| +8.37% | +8.76% | +17.05% | -13.29% | 3.1TCr | |
| -0.24% | +2.97% | - | - | 1.48TCr | |
| +8.30% | +12.19% | +62.65% | +129.55% | 1.46TCr | |
| -0.09% | +6.46% | +11.53% | +19.24% | 1.33TCr | |
| +0.70% | +2.97% | +93.04% | +93.04% | 1.26TCr | |
| +10.86% | +10.40% | +6.48% | -30.12% | 1.21TCr | |
| Average | +3.65% | +6.42% | +58.34% | +93.42% | 2.35TCr | |
| Weighted average by Cap. | +3.15% | +6.40% | +66.61% | +114.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,32500Cr 345.33Cr 304.03Cr 280.43Cr 262.28Cr 491.42Cr 33TCr 500.6Cr 3.37TCr 1.31TCr 16TCr 1.3TCr 1.27TCr 56TCr | 6,17100Cr 400.26Cr 352.38Cr 325.03Cr 303.99Cr 569.58Cr 38TCr 580.21Cr 3.91TCr 1.51TCr 19TCr 1.5TCr 1.47TCr 65TCr |
| Net income | 1,39700Cr 91Cr 80Cr 74Cr 69Cr 128.95Cr 8.54TCr 131.36Cr 884.31Cr 342.53Cr 4.21TCr 340.21Cr 332.84Cr 15TCr | 1,68700Cr 109.42Cr 96Cr 89Cr 83Cr 155.71Cr 10TCr 158.62Cr 1.07TCr 413.61Cr 5.09TCr 410.82Cr 401.91Cr 18TCr |
| Net Debt | 2,09300Cr 135.76Cr 119.52Cr 110.25Cr 103.11Cr 193.19Cr 13TCr 196.8Cr 1.32TCr 513.17Cr 6.31TCr 509.71Cr 498.66Cr 22TCr | 1,26700Cr 82Cr 72Cr 67Cr 62Cr 116.92Cr 7.74TCr 119.1Cr 801.84Cr 310.58Cr 3.82TCr 308.48Cr 301.8Cr 13TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | ₩1,72,700.00 | +7.60% | 8,24,946 |
| 23/26/23 | ₩1,60,500.00 | -4.75% | 5,80,032 |
| 22/26/22 | ₩1,68,500.00 | -1.06% | 5,03,668 |
| 19/26/19 | ₩1,70,300.00 | -1.90% | 11,60,752 |
| 18/26/18 | ₩1,73,600.00 | -0.57% | 4,43,187 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
